bpc 157 evexias Anti-Aging / Longevity Nutraceuticals FDA takes coser look at
Description
Watanabe F, Schwarz J, Takenaka S, Miyamoto E, Ohishi N, Nelle E, Hochstrasser R, Yabuta Y
The only European supplier publishing all seven test parameters per batch (purity, identity, content, bioburden, endotoxins, heavy metals class 1 & 2)
S., Otto, A
Pivotal trial result: AOD-9604's Phase 2b trial (536 subjects, 24 weeks) failed its primary endpoint
You might even question if youre putting in enough effort or simply missing some magical formula
